NCT06090318 2023-10-19Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossRain Oncology IncPhase 1/2 Withdrawn
NCT02567396 2017-04-24Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionNational Cancer Institute (NCI)Phase 1 Withdrawn